Chris Nave

Chris Nave is a pharmaceutical executive with over 20 years of experience in the industry. Chris is currently the Director of OccuRx, a spinifex pharmaceuticals company. Prior to their current position, Nave held executive positions at bace therapeutics, melbourne ventures, leiras pharmaceuticals, baker idi heart and diabetes institute, osprey medical, and polyactiva. Nave has a wealth of experience in both the scientific and business aspects of the pharmaceutical industry, and they have played a key role in the development and commercialization of several successful drugs.

Chris Nave has a doctorate from the University of Melbourne.